Virax Biolabs Group Limited (VRAX)

NASDAQ: VRAX · Real-Time Price · USD

Compare

0.2091

-0.0081 (-3.73%)

At close: Feb 12, 2026, 4:00 PM EST

0.2197

+0.0106 (5.07%)

After-hours: Feb 12, 2026, 7:41 PM EST

Virax Biolabs Group Balance Sheet

Financials in millions USD. Fiscal year is April - March.

Millions USD. Fiscal year is Apr - Mar.

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Sep '25 Sep 30, 2025	Mar '25 Mar 31, 2025	Mar '24 Mar 31, 2024	Mar '23 Mar 31, 2023	Mar '22 Mar 31, 2022	Mar '21 Mar 31, 2021
Cash & Equivalents	3.35	4.23	3.59	9.35	0.02	0.02
Short-Term Investments	0.09	0.09	0.08	0.05	0.01	-
Cash & Short-Term Investments	3.44	4.32	3.67	9.4	0.03	0.02
Cash Growth	-53.43%	17.91%	-61.00%	33774.24%	57.51%	-22.06%
Accounts Receivable	0	-	-	-	-	0
Other Receivables	0.17	0.03	0.22	-	-	-
Receivables	0.18	0.03	0.22	-	-	0
Inventory	0.1	0.19	0.18	0.02	0.02	0.02
Prepaid Expenses	0.44	0.35	0.31	0.21	-	-
Total Current Assets	4.15	4.89	4.38	9.63	0.05	0.04
Property, Plant & Equipment	1.53	1.49	1.05	-	-	-
Other Intangible Assets	0.04	0.04	0.05	0.18	-	-
Total Assets	5.72	6.43	5.48	9.81	0.05	0.04
Accounts Payable	0.04	0.06	0.05	0.16	0.85	0.22
Accrued Expenses	0.06	0.19	0.08	0.55	0.4	0.46
Short-Term Debt	0.2	0.37	-	0.16	-	0.18
Current Portion of Leases	0.07	0.05	0.05	-	-	-
Current Unearned Revenue	-	-	-	0.04	-	-
Other Current Liabilities	-	-	-	-	0	0.02
Total Current Liabilities	0.37	0.67	0.17	0.91	1.25	0.87
Long-Term Leases	0.28	0.29	0.18	-	-	-
Total Liabilities	0.64	0.96	0.35	0.91	1.25	0.87
Common Stock	0.01	0	0	0	0	0
Retained Earnings	-26.93	-24.59	-18.53	-11.79	-6.34	-4.63
Comprehensive Income & Other	32.23	30.28	23.89	20.92	5.36	3.98
Total Common Equity	5.31	5.7	5.37	9.13	-0.97	-0.65
Minority Interest	-0.24	-0.23	-0.23	-0.22	-0.22	-0.18
Shareholders' Equity	5.07	5.46	5.14	8.9	-1.2	-0.83
Total Liabilities & Equity	5.72	6.43	5.48	9.81	0.05	0.04
Total Debt	0.54	0.71	0.22	0.16	-	0.18
Net Cash (Debt)	2.9	3.61	3.44	9.24	0.03	-0.16
Net Cash Growth	-57.22%	4.83%	-62.73%	33181.39%	-	-
Net Cash Per Share	0.64	0.97	1.72	8.69	0.03	-0.66
Filing Date Shares Outstanding	6.54	4.34	2.57	1.79	1	1
Total Common Shares Outstanding	6.54	4.34	2.57	1.55	1	0.92
Working Capital	3.78	4.22	4.21	8.73	-1.2	-0.83
Book Value Per Share	0.81	1.31	2.09	5.87	-0.98	-0.70
Tangible Book Value	5.27	5.66	5.32	8.95	-0.97	-0.65
Tangible Book Value Per Share	0.81	1.30	2.07	5.76	-0.98	-0.70
Machinery	1.74	1.49	0.9	0.01	-	-

Updated Sep 30, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.

SEC Filings: 10-K · 10-Q